Josie Gayton
Chief Operating Officer Precirix
Seminars
Tuesday 1st December 2026
From Discovery to First-in-Human: Navigating the Critical Preclinical Decisions That Determine Translational Success
2:30 pm
- Identifying the scientific, operational and regulatory milestones required to successfully advance a radiopharmaceutical from the laboratory into the clinic
- Determining how to generate the right translational data package to de-risk first-in-human studies and strengthen investor confidence
- Understanding the most common challenges encountered when moving from academic innovation to clinical development and how to proactively address them
Wednesday 2nd December 2026
Investor Strategy Panel: From Specialist Therapy to Standard of Care: What Must Happen for RLTs to Become a Commercially Scalable Oncology Modality?
5:30 pm
- Identifying the scientific, clinical and commercial characteristics investors believe will differentiate tomorrow’s category leaders from an increasingly crowded pipeline
- Exploring which risks remain most significant to investment decisions, from manufacturing scalability and reimbursement to target differentiation and regulatory execution
- Evaluating the milestones that create the greatest enterprise value and discussing where capital should be deployed to maximise long-term commercial success
